OGRI GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO

Details for Australian Patent Application No. 2002306968 (hide)

Owner DELTAGEN, INC.

Inventors MATTHEWS, William; BRENNAN, Thomas, J.; MOORE, Mark

Pub. Number AU-A-2002306968

PCT Number PCT/US02/09763

PCT Pub. Number WO2002/079438

Priority 60/280,320 29.03.01 US; 60/324,615 24.09.01 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/280,320 29.03.01 US; 60/324,615 24.09.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002306968

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306969-TRANSGENIC MICE CONTAINING mGluR7 METABOTROPIC GLUTAMATE RECEPTOR GENE DISRUPTIONS

2002306967-TRANSGENIC MICE CONTAINING ABC TRANSPORTER-LIKE APTASE GENE DISRUPTIONS